Vasotec: Effective Blood Pressure Control for Cardiovascular Health
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.08 (0%) | 🛒 Add to cart |
| 90 | $0.72 | $73.61 $65.10 (12%) | 🛒 Add to cart |
| 120 | $0.68 | $98.15 $81.12 (17%) | 🛒 Add to cart |
| 180 | $0.63 | $147.23 $113.17 (23%) | 🛒 Add to cart |
| 270 | $0.60 | $220.84 $161.25 (27%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $294.45 $207.32 (30%) | 🛒 Add to cart |
Vasotec (enalapril maleate) is an angiotensin-converting enzyme (ACE) inhibitor medication clinically proven to manage hypertension and heart failure. This prescription medication works by relaxing blood vessels, allowing blood to flow more smoothly and reducing the heart’s workload. Healthcare professionals frequently prescribe Vasotec as part of comprehensive cardiovascular management strategies due to its established efficacy and tolerability profile in appropriate patient populations.
Features
- Contains enalapril maleate as the active pharmaceutical ingredient
- Available in multiple tablet strengths (2.5 mg, 5 mg, 10 mg, 20 mg)
- Typically administered once or twice daily depending on indication
- Manufactured under strict quality control standards
- Requires prescription and medical supervision
Benefits
- Effectively lowers high blood pressure to reduce cardiovascular risk
- Decreases strain on the heart in patients with heart failure
- Improves survival rates following heart attacks in certain patients
- May help preserve kidney function in diabetic patients with proteinuria
- Reduces hospitalizations for heart failure exacerbations
- Provides 24-hour blood pressure control with appropriate dosing
Common use
Vasotec is primarily indicated for the treatment of hypertension (high blood pressure), either as monotherapy or in combination with other antihypertensive agents. It is also approved for managing symptomatic heart failure, often as adjunctive therapy with diuretics and digitalis. Additionally, Vasotec is used in selected patients with asymptomatic left ventricular dysfunction to prevent overt heart failure development. Some clinicians may prescribe it for diabetic nephropathy to slow progression of renal disease.
Dosage and direction
Dosage must be individualized based on the patient’s clinical condition and response. For hypertension, the usual starting dose is 5 mg once daily, which may be increased to 10-40 mg daily administered in one or two divided doses. For heart failure, treatment typically begins with 2.5 mg once daily under close medical supervision, with gradual titration to a target maintenance dose of 10-20 mg daily in divided doses. Tablets should be swallowed whole with water, with or without food, though consistency in administration relative to meals is recommended. Dosage adjustments are necessary for patients with renal impairment.
Precautions
Patients should be monitored for hypotension, especially during initial dosing and titration periods. Renal function and serum potassium should be assessed periodically, particularly in patients with pre-existing renal impairment, diabetes, or those taking potassium supplements or potassium-sparing diuretics. Angioedema may occur at any time during treatment, requiring immediate medical attention. Vasotec may cause fetal harm when administered to pregnant women, particularly during the second and third trimesters. Patients with collagen vascular disease or receiving immunosuppressive therapy may be at increased risk for hematologic reactions.
Contraindications
Vasotec is contraindicated in patients with a history of angioedema related to previous ACE inhibitor treatment. It should not be used in patients with hereditary or idiopathic angioedema. Concomitant use with aliskiren-containing products is contraindicated in patients with diabetes. Vasotec is contraindicated during pregnancy due to potential fetal injury and death. The medication should not be administered to patients who have demonstrated hypersensitivity to any component of this product or other ACE inhibitors.
Possible side effect
Common adverse reactions may include dizziness (4-8%), headache (2-5%), fatigue (2-3%), and cough (1-2%). Less frequently, patients may experience orthostatic hypotension, rash, nausea, diarrhea, or impaired renal function. Serious but rare side effects include angioedema, hyperkalemia, neutropenia/agranulocytosis, hepatic failure, and pancreatitis. Some patients may experience taste disturbance or photosensitivity reactions. Most side effects are mild and transient, though persistent or severe symptoms warrant medical evaluation.
Drug interaction
Vasotec may interact with several medications including diuretics (potentiating hypotensive effects), potassium supplements or potassium-sparing diuretics (increasing hyperkalemia risk), lithium (elevating lithium levels), nonsteroidal anti-inflammatory drugs (possibly reducing antihypertensive effect and worsening renal function), and oral hypoglycemics (potentiating hypoglycemic effects). Concurrent use with angiotensin receptor blockers or aliskiren may increase risks of hypotension, hyperkalemia, and renal impairment. Gold injections may rarely cause nitritoid reactions.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed dose. Consistency in medication administration is important for maintaining stable blood pressure control, so establishing a routine is recommended.
Overdose
Vasotec overdose may manifest as pronounced hypotension, which could progress to shock. Bradycardia, electrolyte disturbances, and renal failure may also occur. Management primarily involves supportive care, including volume expansion with normal saline to treat hypotension. Enalaprilat, the active metabolite of Vasotec, may be removed from the body by hemodialysis. Patients suspected of overdose should receive immediate medical attention with appropriate monitoring of vital signs and electrolyte status.
Storage
Vasotec tablets should be stored at controlled room temperature (20-25°C or 68-77°F) in their original container with the lid tightly closed. The medication should be protected from excessive moisture and light. Keep out of reach of children and pets. Do not use tablets that have passed their expiration date or show signs of deterioration. Proper disposal of unused medication through take-back programs is recommended to prevent accidental ingestion or environmental contamination.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Vasotec is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients should not initiate, discontinue, or change dosage without consulting their physician. Individual responses to medication may vary, and only a healthcare provider can determine the appropriate treatment based on a patient’s specific medical condition, history, and current medications.
Reviews
Clinical studies have demonstrated Vasotec’s efficacy in reducing blood pressure and improving outcomes in heart failure patients. In the SOLVD treatment trial, enalapril significantly reduced mortality and hospitalizations for heart failure. Many physicians consider it a well-established option with a favorable risk-benefit profile when used appropriately. Patient experiences vary, with many reporting effective blood pressure control, though some discontinue due to side effects such as persistent cough. The medication has maintained its position in treatment guidelines for decades, reflecting its established role in cardiovascular management.